$EXPO
EXPONENT INC

2017 Q1 Form 10-Q Financial Statement

#000114420417024858 Filed on May 05, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016 Q2
Revenue $84.12M $77.01M $83.16M
YoY Change 14.17% -2.51% 3.57%
Cost Of Revenue $3.700M $4.300M $4.200M
YoY Change -5.13% -4.44% 0.0%
Gross Profit $80.50M $72.80M $79.00M
YoY Change 15.33% -2.28% 3.81%
Gross Profit Margin 95.69% 94.53% 95.0%
Selling, General & Admin $58.60M $50.60M $55.50M
YoY Change 20.82% 8.12% 1.65%
% of Gross Profit 72.8% 69.51% 70.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.600M $1.600M $1.400M
YoY Change 6.67% 23.08% 0.0%
% of Gross Profit 1.99% 2.2% 1.77%
Operating Expenses $69.49M $57.80M $66.72M
YoY Change 25.2% -0.47% 2.23%
Operating Profit $14.63M $14.95M $16.44M
YoY Change 2.49% -28.55% 9.37%
Interest Expense $200.0K $200.0K $100.0K
YoY Change 100.0%
% of Operating Profit 1.37% 1.34% 0.61%
Other Income/Expense, Net $2.776M $1.600M $1.298M
YoY Change 73.5% -174.49% -36.47%
Pretax Income $17.41M $16.79M $17.73M
YoY Change 8.83% -10.56% 3.88%
Income Tax $834.0K $6.400M $2.384M
% Of Pretax Income 4.79% 38.12% 13.44%
Net Earnings $16.58M $10.39M $15.35M
YoY Change 68.28% -11.36% 48.55%
Net Earnings / Revenue 19.7% 13.49% 18.46%
Basic Earnings Per Share $0.32 $0.40 $0.58
Diluted Earnings Per Share $0.31 $0.39 $0.56
COMMON SHARES
Basic Shares Outstanding 52.60M 26.26M shares 26.51M shares
Diluted Shares Outstanding 53.96M 26.96M shares 27.24M shares

Balance Sheet

Concept 2017 Q1 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $154.9M $173.7M $155.0M
YoY Change -9.73% 14.81% 6.9%
Cash & Equivalents $87.09M $115.0M $98.54M
Short-Term Investments $67.80M $58.80M $56.50M
Other Short-Term Assets $12.40M $12.90M $11.70M
YoY Change -1.59% -46.25% -50.63%
Inventory
Prepaid Expenses
Receivables $96.35M $87.41M $94.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $263.6M $274.0M $261.7M
YoY Change -3.36% 1.69% 1.9%
LONG-TERM ASSETS
Property, Plant & Equipment $36.57M $36.71M $28.50M
YoY Change 28.39% 24.86% 3.31%
Goodwill $8.607M $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $952.0K $1.064M $78.70M
YoY Change -42.34% -98.27% 6690.34%
Total Long-Term Assets $134.6M $129.7M $115.7M
YoY Change 17.31% 30.35% 15.22%
TOTAL ASSETS
Total Short-Term Assets $263.6M $274.0M $261.7M
Total Long-Term Assets $134.6M $129.7M $115.7M
Total Assets $398.2M $403.7M $377.4M
YoY Change 2.76% 9.42% 5.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.20M $3.193M $8.200M
YoY Change 181.61% -64.12% -7.87%
Accrued Expenses $41.10M $6.880M $40.00M
YoY Change 490.69% -87.42% -0.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $57.42M $80.24M $54.70M
YoY Change -28.65% 15.28% -0.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.117M $2.005M $50.10M
YoY Change 10.66% -95.29% 2423.93%
Total Long-Term Liabilities $2.117M $2.005M $50.10M
YoY Change 10.66% -95.29% 2423.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.42M $80.24M $54.70M
Total Long-Term Liabilities $2.117M $2.005M $50.10M
Total Liabilities $113.5M $130.4M $104.9M
YoY Change -9.02% 16.22% 1.43%
SHAREHOLDERS EQUITY
Retained Earnings $296.0M $291.2M $273.5M
YoY Change 9.94% 10.25%
Common Stock $205.3M $194.7M
YoY Change 14.15%
Preferred Stock
YoY Change
Treasury Stock (at cost) $213.7M $209.4M $189.2M
YoY Change 15.81% 13.3%
Treasury Stock Shares 6.982M shares 7.256M shares 6.899M shares
Shareholders Equity $284.7M $273.3M $272.5M
YoY Change
Total Liabilities & Shareholders Equity $398.2M $403.7M $377.4M
YoY Change 2.75% 9.42% 5.64%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income $16.58M $10.39M $15.35M
YoY Change 68.28% -11.36% 48.55%
Depreciation, Depletion And Amortization $1.600M $1.600M $1.400M
YoY Change 6.67% 23.08% 0.0%
Cash From Operating Activities -$1.784M $29.70M $300.0K
YoY Change -106.81% 52.31% -82.35%
INVESTING ACTIVITIES
Capital Expenditures $1.307M -$1.300M $1.481M
YoY Change -230.7% -149.22% 136.2%
Acquisitions
YoY Change
Other Investing Activities -$9.000M -$7.000M -$10.60M
YoY Change -53.37% -22.22% -421.21%
Cash From Investing Activities -$10.31M -$8.300M -$12.00M
YoY Change -48.98% -28.45% -544.44%
FINANCING ACTIVITIES
Cash Dividend Paid $5.374M $4.628M
YoY Change 15.04%
Common Stock Issuance & Retirement, Net $1.304M $3.500M
YoY Change 0.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$15.91M -4.400M -15.40M
YoY Change 253.51% -71.05% 52.48%
NET CHANGE
Cash From Operating Activities -$1.784M 29.70M 300.0K
Cash From Investing Activities -$10.31M -8.300M -12.00M
Cash From Financing Activities -$15.91M -4.400M -15.40M
Net Change In Cash -$28.00M 17.00M -27.10M
YoY Change -1966.6% -332.88% 375.44%
FREE CASH FLOW
Cash From Operating Activities -$1.784M $29.70M $300.0K
Capital Expenditures $1.307M -$1.300M $1.481M
Free Cash Flow -$3.091M $31.00M -$1.181M
YoY Change -111.36% 83.88% -210.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
78950000 USD
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
80467000 USD
CY2017Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
3655000 USD
CY2016Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
4206000 USD
CY2017Q1 us-gaap Revenues
Revenues
84122000 USD
CY2016Q2 us-gaap Revenues
Revenues
83156000 USD
CY2017Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
54418000 USD
CY2016Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
52017000 USD
CY2017Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7191000 USD
CY2016Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6983000 USD
CY2017Q1 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
3655000 USD
CY2016Q2 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4206000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4224000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3514000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14634000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
16436000 USD
CY2017Q1 us-gaap Investment Income Net
InvestmentIncomeNet
234000 USD
CY2016Q2 us-gaap Investment Income Net
InvestmentIncomeNet
139000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2542000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1159000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
16576000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
15350000 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26302000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26513000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26981000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27239000 shares
CY2017Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114967000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87086000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2117000 USD
CY2016Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
46503000 USD
CY2017Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
52399000 USD
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1654000 USD
CY2017Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1525000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
130398000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
113457000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
194632000 USD
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
205273000 USD
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
834000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17410000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17734000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
136000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000 USD
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
36000 USD
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
85000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16748000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15430000 USD
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
58755000 USD
CY2017Q1 us-gaap Short Term Investments
ShortTermInvestments
67817000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
87409000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96346000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12913000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12368000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
274044000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
263617000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36710000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36572000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
8607000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
8607000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
42166000 USD
CY2017Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
41715000 USD
CY2016Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
41153000 USD
CY2017Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
46699000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1064000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
952000 USD
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10073000 USD
CY2017Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10204000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62539000 USD
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
41067000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7624000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6145000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80236000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
57416000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2005000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
291243000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
296025000 USD
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
209436000 USD
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
213672000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
273346000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
284705000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9395000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6769000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2974000 USD
CY2016Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-728000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2300000 USD
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12491000 USD
CY2016Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11944000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1479000 USD
CY2016Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1291000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2844000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2980000 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-110000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-146000 USD
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1566000 USD
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1403000 USD
CY2017Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
CY2016Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-22000 USD
CY2017Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-129000 USD
CY2016Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-110000 USD
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
458000 USD
CY2016Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
434000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5655000 USD
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5220000 USD
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
426000 USD
CY2016Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-430000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1784000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
313000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1307000 USD
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1481000 USD
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
CY2016Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
1450000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10307000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-12031000 USD
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9517000 USD
CY2016Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7613000 USD
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1304000 USD
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3500000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
287000 USD
CY2016Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
305000 USD
CY2017Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
5374000 USD
CY2016Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
4628000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-15908000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-15436000 USD
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
118000 USD
CY2016Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-62000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27881000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27216000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125751000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98535000 USD
CY2017Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9000000 USD
CY2016Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
12000000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
13138000 USD
CY2017Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
133655000 USD
CY2017Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
58320000 USD
CY2017Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
58320000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
21918000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
128940000 USD
CY2016Q4 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
53617000 USD
CY2016Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
53617000 USD
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
155086000 USD
CY2017Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
2000 USD
CY2017Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
185000 USD
CY2017Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
154903000 USD
CY2017Q1 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
24000000 USD
CY2017Q1 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
44000000 USD
CY2017Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
68000000 USD
CY2017Q1 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
23971000 USD
CY2017Q1 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
43846000 USD
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
446000 USD
CY2016Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1001000 USD
CY2016Q2 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6334000 USD
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
405000 USD
CY2016Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
223000 USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3661000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3417000 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
EXPONENT INC
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000851520
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-29
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q1 dei Trading Symbol
TradingSymbol
EXPO
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25871157 shares
CY2016Q4 us-gaap Assets
Assets
403744000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2954000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3126000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
398162000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
403744000 USD
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6982000 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7256000 shares
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
69488000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
66720000 USD
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4659000 USD
CY2016Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4607000 USD
CY2016 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2016 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18569000 USD
CY2017Q1 expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2016Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2016Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
72724 shares
CY2016Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3500000 USD
CY2017Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
56003000 USD
CY2016Q2 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5791000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1298000 USD
CY2017Q1 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2017Q1 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2016Q2 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2776000 USD
CY2017Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Use of Estimates. <font style="FONT-WEIGHT: normal">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name View Source Status
0001144204-17-024858-index-headers.html Edgar Link pending
0001144204-17-024858-index.html Edgar Link pending
0001144204-17-024858.txt Edgar Link pending
0001144204-17-024858-xbrl.zip Edgar Link pending
expo-20170331.xml Edgar Link completed
expo-20170331.xsd Edgar Link pending
expo-20170331_cal.xml Edgar Link unprocessable
expo-20170331_def.xml Edgar Link unprocessable
expo-20170331_lab.xml Edgar Link unprocessable
expo-20170331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v464839_10q.htm Edgar Link pending
v464839_ex31-1.htm Edgar Link pending
v464839_ex31-2.htm Edgar Link pending
v464839_ex32-1.htm Edgar Link pending
v464839_ex32-2.htm Edgar Link pending